BIRLAMCHI TIBBIY-SANITARIYA YORDAMI MUASSASASIDA ONKOSKRININGNI TASHKIL ETISH VA SUT BEZI SARATONINI ERTA ANIQLASH NATIJALARINING TAHLILI
DOI:
https://doi.org/10.5281/zenodo.22260716Keywords:
sut bezi saratoni, onkoskrining, birlamchi tibbiy-sanitariya yordami, erta aniqlash, skrining, profilaktik ko‘rik, C50Abstract
Sut bezi saratoni ayollar orasida eng ko‘p uchraydigan onkologik kasalliklardan biri bo‘lib, uni erta aniqlash o‘z vaqtida tashxis qo‘yish va davolashni boshlash uchun muhim ahamiyatga ega. 2022-yilgi GLOBOCAN ma’lumotlariga ko‘ra, dunyoda 2,3 millionga yaqin yangi sut bezi saratoni holati qayd etilgan bo‘lib, ushbu kasallik ayollar orasida eng ko‘p tashxis qilinadigan saraton turi bo‘lib qolmoqda [1,2]. Birlamchi tibbiy-sanitariya yordami muassasalarida skrining tadbirlarini tizimli tashkil etish aholining profilaktik tekshiruvlar bilan qamrovini oshirish hamda shubhali holatlarni keyingi diagnostik bosqichga o‘z vaqtida yo‘naltirish imkonini beradi [3–5]. Birlamchi tibbiy-sanitariya yordami muassasasida 2026-yil yanvar–iyul oylarida amalga oshirilgan onkoskrining natijalarini tahlil qilish, sut bezi saratonining birinchi marta aniqlangan holatlari ulushini baholash va skrining jarayonining amaliy ahamiyatini aniqlash. Tadqiqot retrospektiv tahliliy dizayn asosida olib borildi. 2026-yil yanvar–iyul oylarida poliklinikada skrining tekshiruvlaridan o‘tgan jami 865 nafar fuqaroning tibbiy hujjatlari o‘rganildi. Shundan 560 nafar ayol sut bezi saratonini aniqlashga yo‘naltirilgan onkoskrining tekshiruvlariga jalb qilindi. Ma’lumotlar mutlaq sonlar, foiz nisbatlari va aniqlanish ko‘rsatkichi yordamida tavsifiy statistik usulda tahlil qilindi. Onkoskriningdan o‘tgan 560 nafar ayol orasida sut bezi saratonining (ICD-10: C50) 15 ta birinchi marta aniqlangan holati qayd etildi. Aniqlanish ko‘rsatkichi 2,68% ni tashkil etdi. Onkoskriningning eng yuqori oylik qamrovi mart oyida – 152 nafar (27,14%), eng past ko‘rsatkich esa may oyida – 34 nafar (6,07%) qayd etildi. Iyul oyida 39 nafar ayol tekshiruvdan o‘tkazildi. Aniqlangan 15 nafar bemorning barchasi tashxisni tasdiqlash va keyingi davolash taktikasini belgilash uchun ixtisoslashtirilgan onkologik muassasaga yo‘naltirildi. Birlamchi tibbiy-sanitariya yordami muassasasida onkoskriningni tizimli tashkil etish sut bezi saratonining birinchi marta aniqlangan holatlarini aniqlash va bemorlarni keyingi ixtisoslashtirilgan yordamga o‘z vaqtida yo‘naltirish imkoniyatini kengaytiradi. Skrining qamrovini yil davomida barqaror saqlash, xavf guruhidagi ayollarni faol aniqlash va elektron monitoringni takomillashtirish maqsadga muvofiq.References
R.L., Soerjomataram I., Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2024;74(3):229–
doi:10.3322/caac.21834.
International Agency for Research on Cancer. Global Cancer Observatory: Breast Cancer Fact Sheet. GLOBOCAN 2022. Lyon: IARC; 2024.
World Health Organization. Breast cancer. Geneva: WHO; 2026.
World Health Organization. Patient navigation for early detection, diagnosis and treatment of breast cancer: technical brief. Geneva: WHO; 2024. doi:10.1000/9789240100954.
World Health Organization Regional Office for Europe. Cancer screening and early detection: guidance for implementation. Copenhagen: WHO Regional Office for Europe; 2024.
World Health Organization. Global Breast Cancer Initiative: implementation framework. Geneva: WHO; 2023.
Henderson, J. T., Webber, E. M., Weyrich, M. S., Miller, M., & Melnikow, J. (2024). Screening for breast cancer: evidence report and systematic review for the US Preventive Services Task Force. JAMA, 331(22), 1931–1946. https://doi.org/10.1001/jama.2023.25844
US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930. doi:10.1001/jama.2024.5534.
Canadian Task Force on Preventive Health Care. Screening for breast cancer: a systematic review update to inform the Canadian Task Force on Preventive Health Care guideline. Canadian Medical Association Journal. 2024/2025.
European Commission Initiative on Breast Cancer. European breast cancer screening and early detection recommendations. 2021.
Michaels, E., Worthington, R. O., & Rusiecki, J. (2023). Breast cancer: risk assessment, screening, and primary prevention. Medical Clinics of North America, 107(2), 271–284. https://doi.org/10.1016/j.mcna.2022.10.007
Evans, D. G., et al. (2023). Proactive breast cancer risk assessment in primary care: a review based on the principles of screening. British Journal of Cancer. 2023. doi:10.1038/s41416-023-02145-w. 41416–023. https://doi.org/10.1038/s41416-023-02145-w
Pleasant, V., Bapaye, C., Delporte, F., et al. (2025). National policies for screening and early detection of breast cancer around the globe: practices, barriers, and solutions. International Journal of Gynecology & Obstetrics, 171(3), 1046–1053. https://doi.org/10.1002/ijgo.70545
Sala, D. C. P., Okuno, M. F. P., Taminato, M., et al. (2021). Breast cancer screening in Primary Health Care in Brazil: a systematic review. Revista Brasileira de Enfermagem. 2021;74(3):e20200995. doi:10.1590/0034-7167- 2020-0995. https://doi.org/10.1590/0034-7167-
Racine, L., D’Souza, M. S., & Tinampay, C. (2023). Effectiveness of breast cancer screening interventions in improving screening rates and preventive activities in Muslim refugee and immigrant women: a systematic review and meta-analysis. Journal of Nursing Scholarship, 55(1), 329–344. https://doi.org/10.1111/jnu.12818
Tadesse, G. F., Tegaw, E. M., & Abdisa, E. K. (2023). Diagnostic performance of mammography and ultrasound in breast cancer: a systematic review and meta-analysis. Breast Disease, 26(2), 355–367. https://doi.org/10.1007/
Hussein, H., Abbas, E., Keshavarzi, S., et al. (2023). Supplemental breast cancer screening in women with dense breasts and negative mammography: a systematic review and meta-analysis. Radiology. 2023;306(3):e221785. doi:10.1148/radiol.221785. e221785. doi:10.1148/radiol.221785. https://doi.org/10.1148/radiol.221785
Yoon, J. H., Strand, F., Baltzer, P. A. T., et al. (2023). Standalone AI for breast cancer detection at screening digital mammography and digital breast tomosynthesis: a systematic review and meta-analysis. Radiology. 2023;307(5):e222639. doi:10.1148/radiol.222639. e222639. doi:10.1148/radiol.222639. https://doi.org/10.1148/radiol.222639
Wong, D. J., Gandomkar, Z., Lewis, S., et al. (2023). Do reader characteristics affect diagnostic efficacy in screening mammography? A systematic review. Clinical Breast Cancer. 2023;23(3):e56–e67. doi:10.1016/j. clbc.2023.01.009. 10.1016/j. clbc.2023.01.009. https://doi.org/10.1016/j
Flemban, A. F. (2023). Overdiagnosis due to screening mammography for breast cancer among women aged 40 years and over: a systematic review and meta-analysis. Journal of Personalized Medicine. 2023;13(3):523. doi:10.3390/jpm13030523. https://doi.org/10.3390/jpm13030523
Li, T., Nickel, B., Ngo, P., et al. (2023). A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis. The Breast, 67, 78–88. https://doi.org/10.1016/j.breast.2023.01.001
Tavakoli, B., Feizi, A., Zamani-Alavijeh, F., et al. (2024). Factors influencing breast cancer screening practices among women worldwide: a systematic review of observational and qualitative studies. BMC Women’s Health. 2024;24:268. doi:10.1186/s12905-024-03096-x. 12905–024. https://doi.org/10.1186/s12905-024-03096-x
American College of Radiology. ACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 update. Journal of the American College of Radiology. 2024;21(6S):S126–S143. doi:10.1016/j. jacr.2024.02.019.
American College of Obstetricians and Gynecologists. Age to initiate routine breast cancer screening: ACOG Clinical Practice Update. Obstetrics & Gynecology. 2025;145(1):e40–e44. doi:10.1097/ AOG.0000000000005757.
European Society for Medical Oncology. Early breast cancer: ESMO Clinical Practice Guideline. Annals of Oncology. 2024.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Screening and Diagnosis. 2024.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. 2024.
International Agency for Research on Cancer. Atlas of Breast Cancer Early Detection. Lyon: IARC; 2024.
International Agency for Research on Cancer. Breast cancer screening: IARC Handbook of Cancer Prevention. Lyon: IARC; 2021.
IARC/WHO. Breast cancer screening and early detection resources. Lyon: International Agency for Research on Cancer; 2024.
Sung, H., Ferlay, J., Siegel, R. L., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers. CA: A Cancer Journal for Clinicians, 71(3), 209–249.
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021). Cancer statistics, 2021. CA: A Cancer Journal for Clinicians, 71(1), 7–33.
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022). Cancer statistics, 2022. CA: A Cancer Journal for Clinicians, 72(1), 7–33.
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17–48.
Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024). Cancer statistics, 2024. CA: A Cancer Journal for Clinicians, 74(1), 12–49.
Downloads
Published
How to Cite
Issue
Section
